The global glycomics market is projected to exhibit a significant growth, at a CAGR of around 13.5%, during the forecast period. Proteomics is referred to large-scale study of overall proteomes present in a tissue, cell, or an organism. It comprises identi?cation and quanti?cation technologies and also uses technologies such as genomic and transcriptomics. Research has shown that in neurological diseases such as schizophrenia, some proteins are differentially expressed. Identification of these proteins can lead to new diagnostic tests using protein profiling platforms. Proteomics researches also contribute significantly towards various aspects of the plant, animal and bacterial proteomics at the global level.
Browse the full report description of "Global Glycomics/Glycobiology Market Size, Share & Trends Analysis Report by Product Type (Reagents and Kits, Instruments, Enzymes, and Carbohydrates), by Application (Drug Discovery and Disease Diagnostics) and by End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Clinics) and Forecast 2019-2025" at https://www.omrglobal.com/industry-reports/glycomics-glycobiology-market
The Proteomics Society, India (PSI) in 2009 was established as a platform. This was aimed at encourage the interactions amid the Indian proteomics community and promote the exchange of ideas, collaborations, and innovations at the national as well as at the international levels. In India, although the proteomics research development was slow at the beginning, a significant expansion has been seen in the proteomics community in the last few years. There are more than 100 research laboratories present in nearly 76 research or academic institutes in India that are insistently involved in the investigation of proteome-level researches. Various research groups from India are involved in high quality research on proteomics of various infectious diseases and human cancers, which in turn, is offering growth to the global glycomics market.
Along with India, several other countries such as the US and China are performing research on proteomics for drug discovery, and contributing in the growth of the global glycomics market. A research team from the University of Southern Denmark has discovered 352 proteins expressed in rat brain tissue that may be differentially expressed in human schizophrenia. The research team used a mass spectrometry platform to identify changes in protein in rat brains when they are given the drug phenocyclidine (PCP), which produces symptoms very similar to schizophrenia in rats. This research may have direct implications for developing a diagnostic test that profiles some of these differentially expressed proteins.
The Centre for Proteome Research at the University of Liverpool is a well-equipped lab for addressing challenges in protein mass spectrometry and proteomics. The facility is also a shared research facility within the University’s Technology Directorate. Study of the role of proteomics in studies of protein lighting and development of the method for absolute quantification of equine acute phase protein is among the research based on proteomics conducted by the Centre for Proteome Research. Moreover, in the US, Stowers Institute for Medical Research offers a multidimensional protein identification technology (MudPIT) which is based on a chromatography-based proteomic approach. MudPIT allows the discovery and identification of low abundance proteins and is extremely sensitive. Stowers Institute for Medical Research uses the spectral counting approach as a label free proteomics quantitation tool.
Global Glycomics/Glycobiology Market-Segmentation
By Product Type
By Application
By End-User
Global Glycomics/Glycobiology Market– Segment by Region
North America
Europe
Asia-Pacific
Rest of the World